Revista Cultura Científica - web logo
Submit Your Research
  • Research Article

Maternal Outcomes in Patients with Morbidly Adherent Placenta

Sajida Karamat1, Sameen Nasir2, Asma Siddique3, Uzma Yaqub4, Noor Azhar5, Hira Atique6
1Department of Obstetrics and Gynecology, Sughra Shafi Medical Complex, Narowal, Pakistan
2Woman Medical Officer, Department of Obstetrics and Gynecology, Tehsil Headquarters Hospital, Hasilpur, Pakistan
3Consultant Gynecologist and Obstetrician, District Headquarters Hospital, Sheikhupura, Pakistan
4Professor, Department of Obstetrics and Gynecology, Sughra Shafi Medical Complex, Narowal, Pakistan
5MBBS, Allied Hospital, Faisalabad, Pakistan
6Senior Registrar, Department of Obstetrics and Gynecology, Sughra Shafi Medical Complex, Narowal, Pakistan
DOI: https://doi.org/10.70517/revcc2624201
Published: 07/11/2026
: Sajida Karamat, Sameen Nasir, Asma Siddique, Uzma Yaqub, Noor Azhar, Hira Atique. Maternal Outcomes in Patients with Morbidly Adherent Placenta. Revista Cultura Científica, 2026 Issue 24. pg. 2506-2514.

Abstract

Morbidly adherent placenta (MAP), also termed placenta accreta spectrum (PAS), is a serious obstetric condition associated with substantial maternal morbidity, including severe hemorrhage, peripartum hysterectomy, and admission to an intensive care unit (ICU). Timely diagnosis and coordinated management are important components of care. This study assessed maternal outcomes among women with MAP at a single hospital. A descriptive case series was conducted in the Department of Obstetrics and Gynecology, Sughra Shafi Medical Complex, Narowal, Pakistan, from November 2025 to April 2026. Consecutive non-probability sampling was used to enroll 104 pregnant women aged 20–40 years with MAP and a gestational age exceeding 20 weeks. Demographic characteristics, obstetric variables, and maternal outcomes were recorded using a structured form. Data were analyzed using SPSS version 31.0 and summarized as frequencies, percentages, means, and standard deviations. Stratified comparisons were also performed. Mean maternal age was 29.90 ± 6.03 years. Placenta accreta was the most frequent subtype, accounting for 65.4% of cases, followed by increta (20.2%) and percreta (14.4%). Intraoperative blood loss exceeding 1,500 mL occurred in 38.5% of patients, ICU admission was required in 27.9%, and peripartum hysterectomy was performed in 40.4%. None of the reported stratified associations reached the prespecified significance threshold. These findings demonstrate a substantial burden of maternal morbidity among women treated for MAP at this institution. They support careful perioperative preparation and coordinated obstetric care, although this descriptive case series did not compare management strategies or establish their effectiveness.

Keywords: Intensive Care Units; Maternal Mortality; Obstetric Surgical Procedures; Placenta Accreta; Postpartum Hemorrhage; Pregnancy Outcome

Abstract

Morbidly adherent placenta (MAP), also termed placenta accreta spectrum (PAS), is a serious obstetric condition associated with substantial maternal morbidity, including severe hemorrhage, peripartum hysterectomy, and admission to an intensive care unit (ICU). Timely diagnosis and coordinated management are important components of care. This study assessed maternal outcomes among women with MAP at a single hospital. A descriptive case series was conducted in the Department of Obstetrics and Gynecology, Sughra Shafi Medical Complex, Narowal, Pakistan, from November 2025 to April 2026. Consecutive non-probability sampling was used to enroll 104 pregnant women aged 20–40 years with MAP and a gestational age exceeding 20 weeks. Demographic characteristics, obstetric variables, and maternal outcomes were recorded using a structured form. Data were analyzed using SPSS version 31.0 and summarized as frequencies, percentages, means, and standard deviations. Stratified comparisons were also performed. Mean maternal age was 29.90 ± 6.03 years. Placenta accreta was the most frequent subtype, accounting for 65.4% of cases, followed by increta (20.2%) and percreta (14.4%). Intraoperative blood loss exceeding 1,500 mL occurred in 38.5% of patients, ICU admission was required in 27.9%, and peripartum hysterectomy was performed in 40.4%. None of the reported stratified associations reached the prespecified significance threshold. These findings demonstrate a substantial burden of maternal morbidity among women treated for MAP at this institution. They support careful perioperative preparation and coordinated obstetric care, although this descriptive case series did not compare management strategies or establish their effectiveness.

Keywords: Intensive Care Units; Maternal Mortality; Obstetric Surgical Procedures; Placenta Accreta; Postpartum Hemorrhage; Pregnancy Outcome

References

  1. Jauniaux E, Jurkovic D, Hussein AM, Burton GJ. New insights into the etiopathology of placenta accreta spectrum. Am J Obstet Gynecol. 2022;227(3):384-91. DOI: 10.1016/j.ajog.2022.02.038

  2. Jauniaux E, Aplin JD, Fox KA, Afshar Y, Hussein AM, Jones CJ, et al. Placenta accreta spectrum. Nat Rev Dis Primers. 2025;11(1):40. DOI: 10.1038/s41572-025-00624-3

  3. Akhtar O, Yasmin H, Malik S, Naseeb S. Frequency and clinical outcome in patients with placenta accreta spectrum. J Soc Obstet Gynaecol Pak. 2022;12(1):43-6. Available at: https://jsogp.net/index.php/jsogp/article/view/473

  4. Tahseen H, Khokhar S, Qurban S, Khurshid N, Tayyab M, Muneer N. Morbidly adherent placenta in patients with placenta previa and feto-maternal outcomes. J Soc Obstet Gynaecol Pak. 2023;13(2):69-72. Available at: https://www.jsogp.net/index.php/jsogp/article/view/596

  5. Mohamed M, AbouSekein I, Attia A. Prevalence and types of abnormally adherent placenta in women with CS. Al-Azhar Int Med J. 2022;3(11):77-82. DOI: 10.21608/aimj.2022.138762.1948

  6. Pan S, Han M, Zhai T, Han Y, Lu Y, Huang S, et al. Maternal outcomes of conservative management and cesarean hysterectomy for placenta accreta spectrum disorders: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2024;24:463. DOI: 10.1186/s12884-024-06658-x

  7. Javinani A, Qaderi S, Hessami K, Shainker SA, Shamshirsaz AA, Fox KA, et al. Delivery outcomes in the subsequent pregnancy following the conservative management of placenta accreta spectrum disorder: a systematic review and meta-analysis. Am J Obstet Gynecol. 2024;230(5):485-492.e7. DOI: 10.1016/j.ajog.2023.10.047

  8. Morlando M, Collins S. Placenta accreta spectrum disorders: challenges, risks, and management strategies. Int J Womens Health. 2020;12:1033-45. DOI: 10.2147/IJWH.S224191

  9. Pinto PV, Freitas G, Vieira RJ, Aryananda RA, Nieto-Calvache AJ, Palacios-Jaraquemada JM. Placenta accreta spectrum disorder: a systematic review and meta-analysis on conservative surgery. Int J Gynecol Obstet. 2026;172(1):115-36. DOI: 10.1002/ijgo.70322

  10. Rehman S, Bilqis H, Deeba F, Sheyryar S, Urooj A, Khan S. Morbidly adherent placenta: a cross-sectional study in a tertiary care hospital. Pak J Med Dent. 2022;11(4):50-4. DOI: 10.36283/PJMD11-4/008

  11. Iftikhar B, Khan UI, Tariq A, Nasreen S, Anwar R, Khan SR. Multidisciplinary team approach for morbidly adherent placenta: maternal outcomes compared with standard care. Pak J Health Sci. 2026;7(4):92-98. DOI: 10.54393/pjhs.v7i4.3619

  12. Abbas S, Shaikh F, Hasan N, Sadaf. Fetomaternal outcome in morbidly adherent placenta. Pak J Med Health Sci. 2023;17(1):139-141. DOI: 10.53350/pjmhs2023171139

  13. Bonanni G, Lopez-Giron MC, Allen L, Fox K, Silver RM, Hobson SR, et al. Guidelines on placenta accreta spectrum disorders: a systematic review. JAMA Netw Open. 2025;8(7):e2521909. DOI: 10.1001/jamanetworkopen.2025.21909

  14. Yang QM, Zhang C, Zhang YY, Liu CN. Perspective in diagnostic accuracy of prenatal ultrasound and MRI for placenta accreta. J Matern Fetal Neonatal Med. 2025;38(1):2463401. DOI: 10.1080/14767058.2025.2463401

  15. Salmanian B, Einerson BD, Carusi DA, Shainker SA, Nieto-Calvache AJ, Shrivastava VK, et al. Timing of delivery for placenta accreta spectrum: the Pan-American Society for the Placenta Accreta Spectrum experience. Am J Obstet Gynecol MFM. 2022;4(6):100718. DOI: 10.1016/j.ajogmf.2022.100718

  16. Aalipour S, Salmanian B, Fox KA, Clark SL, Shamshirsaz AA, Asl NM, et al. Placenta accreta spectrum: correlation between FIGO clinical classification and histopathologic findings. Am J Perinatol. 2023;40(2):149-54. DOI: 10.1055/s-0041-1728834

  17. Horgan R, Abuhamad A. Placenta accreta spectrum: prenatal diagnosis and management. Obstet Gynecol Clin North Am. 2022;49(3):423-38. DOI: 10.1016/j.ogc.2022.02.004

  18. Palacz B, Kubiś NM, Teper MM, Perz W, Polus A, Wrona JA, et al. Placenta accreta spectrum: diagnostic standards, guideline concordance and contemporary management. J Educ Health Sport. 2026;87:67608. DOI: 10.12775/JEHS.2026.87.67608

  19. Sargent W, Gerry S, Collins SL. A risk-prediction model for placenta accreta spectrum severity from standardized ultrasound markers. Ultrasound Med Biol. 2023;49(2):512-9. DOI: 10.1016/j.ultrasmedbio.2022.09.021

  20. Shteynman L, Monanian G, Torres G, Sabetta G, Li DM, Jin Z, et al. Pathophysiology and management of placenta accreta spectrum. J Dev Biol. 2025;13(4):45. DOI: 10.3390/jdb13040045

  21. Sugai S, Yamawaki K, Sekizuka T, Haino K, Yoshihara K, Nishijima K. Comparison of maternal outcomes and clinical characteristics of prenatally vs. non-prenatally diagnosed placenta accreta spectrum: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023;5(12):101197. DOI: 10.1016/j.ajogmf.2023.101197

  22. Sentilhes L, Seco A, Azria E, Beucher G, Bonnet MP, Branger B, et al. Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study. Am J Obstet Gynecol. 2022;226(6):839.e1-839.e24. DOI: 10.1016/j.ajog.2021.12.013

Sajida Karamat
Department of Obstetrics and Gynecology, Sughra Shafi Medical Complex, Narowal, Pakistan
salmansandhuskp@gmail.com
Sameen Nasir
Woman Medical Officer, Department of Obstetrics and Gynecology, Tehsil Headquarters Hospital, Hasilpur, Pakistan
Asma Siddique
Consultant Gynecologist and Obstetrician, District Headquarters Hospital, Sheikhupura, Pakistan
Uzma Yaqub
Professor, Department of Obstetrics and Gynecology, Sughra Shafi Medical Complex, Narowal, Pakistan
Noor Azhar
MBBS, Allied Hospital, Faisalabad, Pakistan
Hira Atique
Senior Registrar, Department of Obstetrics and Gynecology, Sughra Shafi Medical Complex, Narowal, Pakistan

How to cite:

Sajida Karamat, Sameen Nasir, Asma Siddique, Uzma Yaqub, Noor Azhar, Hira Atique. Maternal Outcomes in Patients with Morbidly Adherent Placenta. Revista Cultura Científica, 2026 Issue 24. pg. 2506-2514.

Publication History

  • Received: 03/08/2026
  • Accepted: 02/11/2026
  • Published: 07/11/2026
Copyright © 2026, Sajida Karamat, Sameen Nasir, Asma Siddique, Uzma Yaqub, Noor Azhar, Hira Atique. Published by Revista Cultura Científica. This article is published as open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) license (http://creativecommons.org/licenses/by/4.0/).

Browse Advance Search